Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease
Darius, H.; Kopp, H.; Mulfinger, A.; Spielberger, M.; Todt, M.; Schuster, C.J.; Meyer, J.
Progress in Clinical and Biological Research 301: 417-421
1989
ISSN/ISBN: 0361-7742 PMID: 2508112 Document Number: 332802
Document emailed within 1 workday
Related Documents
Sabbá, C.; Zupo, V.; Dina, F.; Nazzari, M.; Albano, O. 1988: A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease International Journal of Clinical Pharmacology Therapy and Toxicology 26(5): 249-252Craveri, A.; Tornaghi, G.; Ranieri, R.; Stanzani, M.; Landi, G.; Paganardi, L.; Passaretti, B.; Gallo, E. 1990: Effects of defibrotide after oral and parenteral administration in patients with peripheral obliterative arterial disease (POAD) International Angiology: a Journal of the International Union of Angiology 9(4): 274-277
Shukla, V.; Fatima, J.; Ali, M.; Garg, A. 2018: A Study of Prevalence of Peripheral Arterial Disease in Type 2 Diabetes Mellitus Patients in a Teaching Hospital Journal of the Association of Physicians of India 66(5): 57-60
Ley Pozo, J.; Vega Gómez, M.E.; Rodríguez Pérez, I. 1988: Arterial circulation of the foot in diabetic patients with peripheral arterial disease Angiologia 40(2): 61-63
Rosenthal, S.; Harris, D.T.; Horton, J.; Glick, J.H. 1980: Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 64(10-11): 1115-1117
Prince-Paul, M.; Burant, C.J.; Saltzman, J.N.; Teston, L.J.; Matthews, C.R. 2010: The effects of integrating an advanced practice palliative care nurse in a community oncology center: a pilot study Journal of Supportive Oncology 8(1): 21-27
Quirk, F.; Dickinson, C.; Baune, B.; Leicht, A.; Golledge, J. 2012: Pilot trial of motivational interviewing in patients with peripheral artery disease International Angiology: a Journal of the International Union of Angiology 31(5): 468-473
Diehm, C.; Mörl, H.; Schettler, G. 1983: Effects of metoprolol on the peripheral circulation in patients with peripheral vascular disease Zeitschrift für Kardiologie 72(1): 44-47
Yoshimatsu, K.; Yokomizo, H.; Fujimoto, T.; Umehara, A.; Otani, T.; Matsumoto, A.; Osawa, G.; Ogawa, K. 2007: Pilot study of simplified low-dose S-1 plus CPT-11 as first-line chemotherapy for patients with advanced colorectal cancer Anticancer Research 27(3b): 1657-1661
Constans, J.; Le Hérissier, A.; Roudaut, R.; Durandet, P.; Gosse, P.; Dallocchio, M. 1992: Coronary disease and peripheral arterial disease: contribution of echo-Doppler in the study of the arteries of the neck and lower limbs before the age of 60. Apropos of 76 cases Annales de Cardiologie et d'Angeiologie 41(3): 171-176
Welten, G.M.J.M.; Schouten, O.; Chonchol, M.; Hoeks, S.E.; Bax, J.J.; Van Domburg, R.T.; Poldermans, D. 2009: Prognosis of patients with peripheral arterial disease Journal of Cardiovascular Surgery 50(1): 109-121
Ibels, L.S.; Stewart, J.H.; Mahony, J.F.; Neale, F.C.; Sheil, A.G. 1977: Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis Quarterly Journal of Medicine 46(182): 197-214
Kiesewetter, H.; Jung, F.; Erdlenbruch, W.; Wenzel, E. 1992: Haemodilution in patients with peripheral arterial occlusive disease International Angiology: a Journal of the International Union of Angiology 11(3): 169-175
Meijer, W.T.; Grobbee, D.E.; Hunink, M.G.; Hofman, A.; Hoes, A.W. 2000: Determinants of peripheral arterial disease in the elderly: the Rotterdam study Archives of Internal Medicine 160(19): 2934-2938
Lebrun, T.; Selke, B.; Sailly, J.C.; Boissier, C.; Mosnier, M. 1994: The introduction of economic criteria into the management of arterial disease: an illustration with regard to the socioeconomic consequences of peripheral occlusive arterial disease of the lower limbs Journal of Cardiovascular Pharmacology 23(Suppl 3): S17-S21
Khalil, A.; Ciobanu, N.; Sparano, J.A.; Gucalp, R.; Dutcher, J.P.; Wiernik, P.H. 1995: Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignancies Bone Marrow Transplantation 15(1): 93-97
Abou-Mourad, Y.; Otrock, Z.K.; Makarem, J.A.; Kattan, J.G.; Farhat, F.S.; Jalloul, R.; Mokaddem, W.T.; Ghosen, M.G.; Taher, A.T.; Chehal, A.A.; Shamseddine, A.I. 2008: Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study Le Journal Medical Libanais. Lebanese Medical Journal 56(1): 16-21
Coughlin, P.A.; Gulati, V.; Mavor, A.I.D.; Gough, M.J.; Homer-Vanniasinkam, S. 2007: Risk factor awareness in patients with peripheral arterial disease Journal of Cardiovascular Surgery 48(6): 735-740
Bruhn, C. 2013: Supervised exercise programs for patients with peripheral arterial disease Deutsche Medizinische Wochenschrift 138(17): 872-873
Chen, H.-W.; Liu, H.-E. 2011: Peripheral arterial occlusive disease and its care in hemodialysis patients Hu Li Za Zhi Journal of Nursing 58(2): 16-21